                         SEQUENCE LISTING

<110>  ProQR Therapeutics II B.V.
       Aalto, Antti
       Turunen, Janne J.
 
<120>  OLIGONUCLEOTIDE COMPLEXES FOR USE IN RNA EDITING

<130>  P3053PC00

<150>  GB 1700939.0
<151>  2017-01-19

<150>  GB 1707511.0
<151>  2017-05-10

<160>  20    

<170>  PatentIn version 3.5

<210>  1
<211>  53
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  ADAR59-2

<400>  1
cauugaagaa gauaagagaa aguacugaga aguguuggcc auggaacagg uag              53


<210>  2
<211>  20
<212>  RNA
<213>  Artificial sequence

<220>
<223>  GFP-SON-1/3/5

<400>  2
cuguuccaug gccaacacuu                                                   20


<210>  3
<211>  15
<212>  RNA
<213>  Artificial sequence

<220>
<223>  GFP-SON-2/4/6

<400>  3
guuccauggc caaca                                                        15


<210>  4
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  GFP-SON-7/9

<400>  4
ctgttggatg gccaacactt                                                   20


<210>  5
<211>  15
<212>  DNA
<213>  Artificial sequence

<220>
<223>  GFP-SON-8

<400>  5
gttccatggc caaca                                                        15


<210>  6
<211>  19
<212>  DNA
<213>  Artificial sequence

<220>
<223>  GFP target sequence

<400>  6
cctgttccat agccaacac                                                    19


<210>  7
<211>  16
<212>  DNA
<213>  Artificial sequence

<220>
<223>  GFP target sequence

<400>  7
ttccatagcc aacact                                                       16


<210>  8
<211>  19
<212>  DNA
<213>  Artificial sequence

<220>
<223>  GFP target sequence

<400>  8
tacctgttcc atagccaac                                                    19


<210>  9
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  GFP target sequence

<400>  9
tgttccatag ccaacacttg                                                   20


<210>  10
<211>  22
<212>  DNA
<213>  Artificial sequence

<220>
<223>  GFP target sequence

<400>  10
cctgttccat agccaacact tg                                                22


<210>  11
<211>  28
<212>  DNA
<213>  Mus musculus

<400>  11
tttgccaaga agtagcgcct ttccctat                                          28


<210>  12
<211>  13
<212>  DNA
<213>  Mus musculus

<400>  12
agaagtagcg cct                                                          13


<210>  13
<211>  29
<212>  DNA
<213>  Mus musculus

<400>  13
ttttgccaag aagtagcgcc tttccctat                                         29


<210>  14
<211>  45
<212>  DNA
<213>  Artificial sequence

<220>
<223>  ADAR94-1

<400>  14
gacugaggua cuccuuagag aaaggugcca cuucuuggca aagga                       45


<210>  15
<211>  15
<212>  RNA
<213>  Artificial sequence

<220>
<223>  SON2

<400>  15
aagaaguggc accuu                                                        15


<210>  16
<211>  19
<212>  DNA
<213>  Artificial sequence

<220>
<223>  forward primer Fw1_mSNRPA

<400>  16
gccttcgtgg agtttgaca                                                    19


<210>  17
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  reverse primer Rev1_mSNRPA

<400>  17
acacacggct ctgagaaggt                                                   20


<210>  18
<211>  21
<212>  DNA
<213>  Artificial sequence

<220>
<223>  sequence primer Snrp-1-Fw1

<400>  18
cgtggagttt gacaatgaag t                                                 21


<210>  19
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  forward primer Fw2_mSNRPA

<400>  19
gctctccatg ctcttcaacc                                                   20


<210>  20
<211>  18
<212>  DNA
<213>  Artificial sequence

<220>
<223>  reverse primer Rev2_mSNRPA

<400>  20
tcagggactg agccaagg                                                     18


